From: Reigniting hope in cancer treatment: the promise and pitfalls of IL-2 and IL-2R targeting strategies
Regulator | Type | Function | References |
---|---|---|---|
Nuclear Factor of Activated T-cells (NFAT) | Transcription factor | Binds to the promoter region of IL-2 to promote its expression | |
Activator Protein-1 (AP-1) | Transcription factor | Binds to the enhancer region of IL-2 to promote its expression | |
Nuclear Factor-kappa B (NF-kB] | Transcription factor | Binds to the promoter region of IL-2 to promote its expression | |
Early Growth Response Protein 1 (EGR1] | Transcription factor | Binds to the promoter region of IL-2 to promote its expression | |
Activating Transcription Factor 3 (ATF3) | Transcription factor | Binds to the promoter region of IL-2 to suppress its expression | |
Janus kinases (JAKs) | Positive regulator | Activates Signal Transducer and Activator of Transcription-5 (STAT5) to promote IL-2 receptor signaling | |
Signal Transducer and Activator of Transcription-5 (STAT5) | Positive regulator | Phosphorylated by JAKs to promote IL-2 receptor signaling | |
Suppressor of Cytokine Signaling-1 (SOCS1) | Negative regulator | Inhibits JAK/STAT signaling, leading to reduced IL-2 receptor signaling | |
Forkhead Box P3 (FoxP3) | Negative regulator | Suppresses IL-2 production and IL-2 receptor expression in regulatory T cells | |
Interleukin-2 Inducible T-cell Kinase (ITK) | Positive regulator | Phosphorylates downstream effectors to promote IL-2 receptor signaling | |
Protein Kinase C-theta (PKCθ) | Positive regulator | Phosphorylates downstream effectors to promote IL-2 receptor signaling |